Atlas Trials

Investigating Cabozantinib in Patients With Refractory Metastatic Colorectal Cancer

Clinical trial NCT03542877 · COMPLETED

Trial details

NCT number
NCT03542877
Sponsor
Academic Thoracic Oncology Medical Investigators Consortium
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Colorectal Cancer
Start date
2018-06-01
Primary completion
2020-10-19
Enrollment
44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.